Johnson Investment Counsel Inc Novo Nordisk A S Transaction History

Johnson Investment Counsel Inc

$9.44 Billion
Q2 2024

A detailed history of Johnson Investment Counsel Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 18,728 shares of NVO stock, worth $2.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,728

Previous 18,363 1.99%

Holding current value

$2.1 Million

Previous $2.36 Million 13.41%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$122.71 - $146.91 $44,789 - $53,622	365 Added 1.99%	18,728 $2.67 Million
Q1 2024 May 09, 2024	SELL	$102.11 - $135.92 $279,679 - $372,284	-2,739 Reduced 12.98%	18,363 $2.36 Million
Q4 2023 Feb 07, 2024	BUY	$87.78 - $105.45 $98,840 - $118,736	1,126 Added 5.64%	21,102 $2.18 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $903,761 - $1.98 Million	9,938 Added 99.0%	19,976 $1.82 Million
Q2 2023 Aug 10, 2023	SELL	$155.98 - $172.65 $199,498 - $220,819	-1,279 Reduced 11.3%	10,038 $1.62 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $11,910 - $14,322	-90 Reduced 0.79%	11,317 $1.8 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $210,842 - $278,238	-2,056 Reduced 15.27%	11,407 $1.54 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $15,340 - $18,825	161 Added 1.21%	13,463 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $30,765 - $36,299	-298 Reduced 2.19%	13,302 $1.48 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $1,675 - $2,025	18 Added 0.13%	13,600 $1.52 Million
Q4 2021 Feb 15, 2022	SELL	$95.88 - $117.08 $45,255 - $55,261	-472 Reduced 3.36%	13,582 $1.52 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $261,195 - $329,882	3,094 Added 28.23%	14,054 $1.35 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $11,366 - $14,239	-168 Reduced 1.51%	10,960 $918,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $6,706 - $7,581	-100 Reduced 0.89%	11,128 $761,000
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $6,389 - $7,380	100 Added 0.9%	11,228 $784,000
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $81,956 - $95,116	-1,400 Reduced 11.17%	11,128 $729,000
Q1 2020 May 20, 2020	SELL	$49.46 - $64.78 $55,147 - $72,229	-1,115 Reduced 8.17%	12,528 $765,000
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $60,090 - $67,535	-1,264 Reduced 8.48%	13,643 $705,000
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $98,960 - $110,974	2,115 Added 16.53%	14,907 $760,000
Q1 2019 May 13, 2019	SELL	$46.36 - $52.63 $42,419 - $48,156	-915 Reduced 6.68%	12,792 $669,000
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $3,366 - $3,689	-72 Reduced 0.52%	13,707 $646,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $58,905 - $67,058	1,330 Added 10.68%	13,779 $635,000
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $13,092 - $15,697	-270 Reduced 2.12%	12,449 $613,000
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $5,323 - $6,017	112 Added 0.89%	12,719 $682,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $518,778 - $620,516	12,607	12,607 $607,000

Others Institutions Holding NVO

# of Institutions

1,971

Shares Held

320M

Call Options Held

5.16M

Put Options Held

4.96M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $253B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Novo Nordisk A S Transaction History